| Company Name: |
GLP Pharma Standards
|
| Tel: |
+91 9866074638 |
| Email: |
info@glppharmastandards.com |
| Products Intro: |
Product Name:Enrofloxacin EP Impurity-E
CAS:1369495-59-9
Purity:98% Package:50 MG; 100 MG; 250 MG ; 23 MG
|
| Company Name: |
Guangzhou PI PI Biotech Inc
|
| Tel: |
+86-020-81716320 +86-13602409664 |
| Email: |
Sales@pipitech.com |
| Products Intro: |
Product Name:Enrofloxacin Impurity E(EP)
CAS:1369495-59-9
Purity:90%+ Package:10mg;0USD|25mg;0USD|50mg;0USD|100mg;0USD
|
| Company Name: |
Nanjing XiZe Biotechnology CO., Ltd. Gold
|
| Tel: |
025-58362220 15250997978 |
| Email: |
1511893459@qq.com |
| Products Intro: |
Product Name:Enrofloxacin EP Impurity E
CAS:1369495-59-9
Purity:95% HPLC Package:10mg;25mg;50mg;100mg;250mg;500mg;1g
|
Enrofloxacin EP Impurity E manufacturers
|
| | Enrofloxacin EP Impurity E Basic information |
| Product Name: | Enrofloxacin EP Impurity E | | Synonyms: | Enrofloxacin EP Impurity E;Enrofloxacin Impurity E(EP);6-chloro-1-cyclopropyl-7-(4-ethylpiperazin-1-yl);3-Quinolinecarboxylic acid, 6-chloro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-1,4-dihydro-4-oxo-;6-Chloro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-1,4-dihydro-4-oxo-3-Quinolinecarboxylic Acid;6-chloro-1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride;6-Chloro-1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (Enrofloxacin Impurity) | | CAS: | 1369495-59-9 | | MF: | C19H22ClN3O3 | | MW: | 375.85 | | EINECS: | | | Product Categories: | | | Mol File: | 1369495-59-9.mol |  |
| | Enrofloxacin EP Impurity E Chemical Properties |
| Boiling point | 589.2±50.0 °C(Predicted) | | density | 1.407±0.06 g/cm3(Predicted) | | pka | 6.44±0.41(Predicted) |
| | Enrofloxacin EP Impurity E Usage And Synthesis |
| Uses | 6-Chloro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-1,4-dihydro-4-oxo-3-Quinolinecarboxylic acid can be used to develop and validate the stability indicating RP-?LC method for estimation of related substances of enrofloxacin in bulk and its pharmaceutical formulations |
| | Enrofloxacin EP Impurity E Preparation Products And Raw materials |
|